Real-world effectiveness of second-line Afatinib versus chemotherapy for the treatment of advanced lung squamous cell carcinoma in immunotherapy-naïve patients.
BMC Cancer
; 21(1): 1225, 2021 Nov 15.
Article
in En
| MEDLINE
| ID: mdl-34781919
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Squamous Cell
/
Protein Kinase Inhibitors
/
Afatinib
/
Lung Neoplasms
/
Antineoplastic Agents
Type of study:
Observational_studies
Limits:
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Asia
Language:
En
Journal:
BMC Cancer
Journal subject:
NEOPLASIAS
Year:
2021
Document type:
Article
Affiliation country:
Country of publication: